Baldwin Wealth Partners LLC MA Has $10.10 Million Stock Position in Waters Co. (NYSE:WAT)

Baldwin Wealth Partners LLC MA reduced its stake in Waters Co. (NYSE:WAT) by 2.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 27,235 shares of the medical instruments supplier’s stock after selling 712 shares during the period. Baldwin Wealth Partners LLC MA’s holdings in Waters were worth $10,104,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in WAT. State Street Corp increased its stake in Waters by 1.9% in the third quarter. State Street Corp now owns 2,577,733 shares of the medical instruments supplier’s stock valued at $927,700,000 after purchasing an additional 49,194 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Waters by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 1,416,683 shares of the medical instruments supplier’s stock valued at $508,123,000 after buying an additional 16,703 shares in the last quarter. Janus Henderson Group PLC raised its stake in Waters by 0.7% during the 3rd quarter. Janus Henderson Group PLC now owns 885,593 shares of the medical instruments supplier’s stock worth $318,717,000 after buying an additional 6,256 shares during the period. Van ECK Associates Corp lifted its holdings in Waters by 1.0% during the third quarter. Van ECK Associates Corp now owns 659,539 shares of the medical instruments supplier’s stock worth $219,811,000 after acquiring an additional 6,647 shares in the last quarter. Finally, Principal Financial Group Inc. raised its holdings in Waters by 70.7% during the 3rd quarter. Principal Financial Group Inc. now owns 656,019 shares of the medical instruments supplier’s stock worth $236,095,000 after buying an additional 271,804 shares during the period. 94.01% of the stock is owned by institutional investors and hedge funds.

Waters Stock Performance

Shares of WAT stock opened at $409.43 on Monday. The company has a fifty day moving average price of $381.66 and a two-hundred day moving average price of $354.99. Waters Co. has a one year low of $279.24 and a one year high of $416.24. The stock has a market cap of $24.31 billion, a P/E ratio of 39.14, a P/E/G ratio of 7.17 and a beta of 1.01. The company has a debt-to-equity ratio of 1.14, a current ratio of 2.02 and a quick ratio of 1.38.

Waters (NYSE:WAT) last issued its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.68 by $0.25. The business had revenue of $740.30 million during the quarter, compared to the consensus estimate of $712.99 million. Waters had a net margin of 21.43% and a return on equity of 49.93%. Waters’s revenue was up 4.0% on a year-over-year basis. During the same period last year, the business posted $2.84 EPS. As a group, equities analysts predict that Waters Co. will post 11.79 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently commented on WAT. Wells Fargo & Company raised their price objective on shares of Waters from $380.00 to $415.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Barclays lifted their price target on Waters from $330.00 to $360.00 and gave the company an “underweight” rating in a research note on Monday, November 4th. Scotiabank assumed coverage on Waters in a research report on Monday, December 23rd. They set a “sector perform” rating and a $430.00 price objective for the company. Deutsche Bank Aktiengesellschaft increased their price objective on Waters from $310.00 to $325.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Finally, Stifel Nicolaus boosted their target price on Waters from $332.00 to $360.00 and gave the company a “hold” rating in a research note on Monday, November 4th. One analyst has rated the stock with a sell rating, nine have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $384.71.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.